Skip to content

CeriBell, Inc. CBLL EBITDA margin

EBITDA margin at other companies

IAR
Integra LifeSciencesIART
-19.5%-30.1pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-63.2%-1.4pp
iRadimed logo
iRadimedIRMD
34.1%+2.9pp
Teladoc Health logo
Teladoc HealthTDOC
6.1%+3.3pp
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
-161.7%+25.8pp
Cerence Inc. logo
Cerence Inc.CRNC
11.2%+5.8pp

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

Based on trailing twelve months.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s EBITDA margin?
CeriBell, Inc. (CBLL) reported EBITDA margin of -67% in Q1 2026.
How has CeriBell, Inc.'s EBITDA margin changed year-over-year?
CeriBell, Inc.'s EBITDA margin decreased by 8.3% year-over-year, from -61.8% to -67%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.